Introduction: Homeoprophyalxis (HPx) is the use of potentized homeopathic nosodes^[1] to activate mild short-lived immune responses so as to stimulate immunity to the relative infectious agent. Past research of Homeoprophylaxis, in small- and large-scale applications, has demonstrated safety and efficacy of nosodes, and improved long-term outcomes.^{[2], [3], [4], [5], [6]} These interventions have set a precedence to continue to research the benefits for current public health concerns.

Past research with HPx nosodes has demonstrated that in the hours and days that follow dosing the activated, mild short-lived, immune response that emerges appears to not only develop general immunity to that disease, in addition, through that process improves the long-term health outcomes of the participant. Within homeopathic philosophy is the principle that the discharges released through acute disease processes liberates the chronic disease state^[7]. Furthermore, epidemics and infectious disease outbreaks have historically served as major evolutionary catalysts to human development and the social transformations that have arisen in the wake of these epidemics.^{[8], [9]}

Building on these past results, we will study 8 individual HPx Programs, designed for different age groups and age-related needs, to activate the immune system towards a variety of viral and bacterial disease agents for optimum health in the immune system and associated systems throughout the normal stages of an individual’s lifespan: childhood development, maturation, reproductive years, and aging processes.

Each infectious disease agent has its own evolutionary purpose in the individual for their immunological and adjunctive biological systems development.The working hypothesis is each infectious agent poses a conflict-resolution pathway for the immune system to harmonize when delivered in the right strength.^[10] When disease is delivered orally in potency, the individual can gain the benefit of the disease without the suffering of the actual disease. When supported with disease specific homeopathic remedies the immunological responses activated can be even more fully integrated.

Moreover, delivering these doses in sequential dosing patterns may potentiate disease specific beneficial effects.

This research has five goals:

1. To evaluate HPx Program compliance.
2. To determine the conflict-resolution process of each infectious agent though dosing with potentized preparations.
3. To evaluate the safety of each nosode from the dosing responses generated.
4. To ascertain the benefits of mild immune stimulation throughout the normal stages of an individual’s maturation depending on the HPx Program selected. Vis: childhood development, sexual and neurological maturation, viable reproductive years, aging processes, etc.
5. To determine an individual’s cumulative health outcome upon completion of the selected HPx Program.

Background: Human immune system development and function is directly related to the adjunctive biologic systems of neurology, digestion, intellectual capacity, discernment, and the human self-individuation process. For the last seven decades, due to direct and indirect immune suppression of normal infectious disease expression from vaccines, antibiotics, immunomodulating drugs, manmade pathogens, and a host of other interventions, there has been a systematic breakdown of normal immune system function in children, young adults, sexually mature adults, and aging populations. All are suffering from a compounded multi-generational, multi-infectious disease miasmatic burden.^{[11], [12], [13]}

The relative health and susceptibility of the individual exposed to infectious disease is the main factor determining the degree and efficacy of the appropriate immune response to that disease. The long-term trajectory of the health of humanity depends on exploring alternative methods of building general health while maintaining immune system integrity, not only for the individual but the population at large.

General consensus in the population is that we need an alternative to the current vaccine model for immune system management. Homeoprophylaxis is one such model.

Method: Registranst will partner with an HPx Practitioner and register into their private practice to get set up with their program of choice. Each HPx Program is designed for the immunological needs of a specific age-group. Each HPx Program consists of sequential dosing, through a scheduled timeframe, with a variety of targeted nosodes separately or in conjunction with associated homeopathic remedies. Each program has its own Inclusion/Exclusion requirements to ensure that participants demonstrate relatively healthy immune system function in relation to the HPx Program registered for. Recorded responses and interpretations within the program specific Dosing Tables will provide the Materia Medica of each agent, the safety of, and the conflict-resolution immune dynamic stimulated. Intake and Exit interviews will determine before and after health status and be used to assess long-term health outcomes.

Results: To be determined.
Conclusions: To be determined.

Search Terms: Chronic disease in children, Homeorpohylaxis, Infertility rates, evolution from childhood Diseases, normal childhood development, immune syste during gestation, use of antibitocs for Group B Strep (GBS), Acute disease liberates chronic disease, features of infant immune systems, immune collapse in the elderly, incidence rates of sexually transmitted disease.

HPx Programs to study

1. Name of program: Main purpose or trajectory of the program. Number of nosodes and remedies, potencies. Duration. Recommended ages of registrants.
2. Healthy Biome HPx: Establishing the foundation of life and vitality. 9 nosodes, 1M potencies. 9 or 18 weeks. Program may be repeated. Recommended for all ages.
3. Full Childhood Immunological HPx: For healthy childhood development and intact immune systems. 10 nosodes, 200C and 10M potencies. 50 months. Recommended for newborns to 18 years of age.
4. Young Adult and College Prep HPx: The emergence of true self and critical thinking through immune system stimulation. 6 nosodes and 6 supportive remedies, 200C and 10M potencies. 6 or 12 months. Recommended for college age young adults (16-24 years).
5. Travel HPx: Healthy immune systems while expanding world view. 5 nosodes and 5 supportive remedies, 200C potencies. Additional remedies may be added based on travel destination, season, and individual needs. 5 or 10 weeks. Recommended for all Ages.
6. Healthy Sexuality and Pre-Procreation HPx: Alignment and corrective immunity to the divine order of life. 7 nosodes and 7 supportive remedies, 200C and 10M potencies. 6 or 12 months. Recommended for individuals or couples (18-45 years).
7. Group B Strep Prevention: For reconciling Group B Streptococcal disease during pregnancy and for pro-creating partners. 1 nosode, 6 potencies. 6 0r 12 weeks. Recommended for both partners pre-conception and/or during pregnancy. (18-45 years).
8. Healthy Pregnancy and Fetal Development HPx: Releasing inherited afflictions to liberate your offspring. 7 nosodes and 7 supportive remedies, 1M potency. 7 months. Recommended during pregnancy (18-45 years).
9. Immune Health for Elders HPx: Activation of immune system memory supporting the role of the elders in family settings. 6 diseases and 6 supporting remedies, 1M potencies. 6 months. Recommended for 55 years and older.
10. Single disease prevention HPx: Single disease or short series. Any time depending on the season, climate, and socio-political issues. Any Nosode or remedies, any potencies. Recommended for any age. Single disease HPx Programs will be based on trending diseases, and custom programs designed for the individual.

Selection criteria: Reasonably healthy individuals who satisfy the Inclusion/Exclusion criteria that correspond to recommended age per specific HPx Program. The supervising HPx Practitioner determines HPx Program readiness.

Ethical constraints: All registrants will Consent to Research through the registration process. They acknowledge they are entering research under their own cognizance and waive any liability to FHCi and their HPx Practitioner through the Private Membership Association they have entered. Patrons can withdraw at any time and choose other medical interventions if desired. All Personal Health Information (PHI) will be held in confidence. All Dosing responses will be verified and assessed for safety. All registrants have access to the Ethics Complaint Process and Adverse Event Reporting System.

Study duration: HPx Program registration uptake on all programs will be continuous and in perpetuity unless halted by FHCi. Each program has its recommended time frame for completion. Data entry will be continuous as more doses are administered in their select program. Subsets of data for analysis can be pulled at any point in the process depending on the parameters studied. Entrance into research will be optional after at least 100 registrants have completed that specific HPx Program. Once the 100-registrant threshold for a specific HPx Program has been met, data collected from that program will be sent for analysis and publication.

Duration of study per registrant: According to the set duration of the HPx Program, plus 2 months (4 months for Full Childhood Immunological HPx Program) for extenuating circumstances, plus 6 months after the final dose is administered.

Supervision: Each registrant will be supervised by an HPx Practitioner who will be their point of contact for questions and interventions, should the need arise throughout their HPx program. Entrance into research does not preclude constitutional homeopathic care which may be needed alongside the HPx program.

Recruitment and Registration:

• Recruitment of participants is through passive selection, direct referral, and social media.
• Registrants will register through Patronship to FHCi and be assigned a unique file number. Through their Patron Portal they will access the individual HPx Programs and HPx Practitioners.
• PHI and non-Private Health Information (non-PHI) will be identified within the secure Patron Portal.
• All data entry will be housed in the Patron Portal.
• After being assessed per the HPx Program Inclusion/ Exclusion criteria they may register for their selected HPx Program under the supervision of an HPx Practitioner.
• All HPx Practitioners operate within their own private practice and have ongoing supervision from FHCi.
• Registrants will schedule to meet with their selected HPx Practitioner in their private practice for an interview and Q and A process to explain how their selected HPx Program works.
• Each program registered for within the Parton Portal requires a nominal administrative fee to FHCi to access.
• HPx Practitioners set their HPx Program Supervision fees within FHCi established guidelines for supervision. This fee includes consultation, documentation, All HPx Programs booklet and HPx Kits.
• Registrants will complete the HPx Program specific Intake, add dosing dates and responses in the Dosing Table, and complete Exit Interview upon completion of the program.
• Dosing dates and remedy responses entered into the Patron Portal by the registrant will be confirmed by the HPx Practitioner.

HPx Program administration: Each program is designed to be self-administered for the individual as per schedule under the direct supervision of a trained HPx Practitioner.

Early exit strategy: At any time in the selected HPx Program a registrant may opt to withdraw from the program. To do so, the Exit Interview must be completed regardless of how much of the program was completed.

Completion strategy: Upon completion of the select program registrants are to complete the specific HPx Program Exit Interview and may print a Final Certificate of Immunization.

Research analysis parameters:

• Number of individuals registered in which programs
• Age and gender of participants
• Previous health status of registrant
• Compliance to recommended dosing schedule and duration of the program
• Number of doses administered per nosode or remedy
• Incidence of remedy responses
• Quality of remedy responses
• Other interventions
• Adverse Event rate
• Disease contraction rate
• Long-term health outcomes relative to HPx Program upon completion of the program

1. Nosodes are defined by the Food and Drug Administration’s (FDA) Homoeopathic Pharmacopoeia of the United States (HPUS) as homoeopathic “attenuations” of pathological organs and/or tissues, causative agents, or disease products from infected individuals, such as discharges, excretions, and secretions.
2. Birch, K., Heng, J., Morse, C. Garrison, S., Wood, C., Calvi-Rooney, G., Dobelmann, U. A Homeopathic Proving of the Coronavirus nosode; Novus-CV. Reference
3. Birch, K., Heng, J., Morse, C. Garrison, S., Wood, C., Calvi-Rooney, G., Dobelmann, U. “Determining the safety, effects, and efficacy of Novus-CV in homeopathic dilution in humans for Covid-19 disease prevention.” Similia, The Australian Journal of Homoeopathic Medicine. Volume 31, Number 2. Hobert Tasmania. June 2021. Reference
4. Birch, K, Sandon, S, Damlo, S, Lane, K. Long-term homoeoprophylaxis study in children in North America. Part One: Factors contributing to the successful completion of sequential dosing of disease nosodes. Similia. Journal of the Australian Society of Homeopaths. Dec. 2019. Reference
5. Birch, K, Sandon, S, Damlo, S, Lane, K. Long-term homoeoprophylaxis study in children in North America. Part Two: Safety of HP, review of immunological responses, and effects on general health outcomes. Similia. Journal of the Australian Society of Homeopaths. June 2020.
6. Golden, I. “Large Homoeoprophylaxis Interventions by Government Institutions.” Similia, The Australian Journal of Homoeopathic Medicine. Volume 31, Number 2. Hobert Tasmania. December 2019. [cited 2021 October 21] Available from: Reference
7. Hahnemann, Samuel. The Chronic Diseases. Introduction. New Delhi: B. Jain Publishers, 1991.
8. Vaccine Free Prevention and Treatment of Infectious Contagious Disease with Homeopathy. A Manual for Practitioners and Consumers. Cholera. Kate Birch, RSHom(NA), CCH, CMT. 2007.
9. Birch, K. Dismantling Covid. 2024. Dismantling Covid: The Evolution of Man (120 min).Reference
10. Bach, E. Health Thy Self. The Bach Center. UK. 2009, Reference
11. CDC Data on Autism Spectrum last viewed (12/2/24) ADDM Network Data Resources | Autism Spectrum Disorder (ASD) | CDC
12. CDC chronic disease in children. (Last view 12/2/24) FastStats - Child Health
13. Hahnemann, Samuel. The Chronic Diseases. Introduction. New Delhi: B. Jain Publishers, 1991.